USE OF A RADIOIMMUNOASSAY FOR 5-HYDROXYTRYPTAMINE (5-HT) IN THROMBOCYTOSIS

被引：2
作者：
RANDI, ML [1 ]
STOCCO, F [1 ]
TISON, T [1 ]
FABRIS, F [1 ]
GIROLAMI, A [1 ]
机构：
[1] UNIV PADUA,SCH MED,INST MED SEMEIOT,CHAIR MED 2,I-35100 PADUA,ITALY
来源：
BLOOD COAGULATION & FIBRINOLYSIS | 1991年 / 2卷 / 01期
关键词：
5-HYDROXYTRYPTAMINE; THROMBOCYTOSIS; RADIOIMMUNOASSAY;
D O I：
10.1097/00001721-199102000-00033
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A decrease in intra-platelet 5-hydroxytryptamine (5-HT) may be a possible marker for primary thrombocytosis and there are several different methods for the measurement of platelet 5-HT content (e.g. fluorimetry, high-performance liquid chromatography and radioimmunoassay). The present study has shown that, in laboratories with radioprotected areas, radioimmunoassay of 5-HT is a simple method which correlates well with a standard fluorimetric technique and yields satisfactory results in patients with thrombocytosis.
引用
收藏
页码：205 / 208
页数：4
相关论文
共 50 条
  • [41] EVIDENCE THAT 5-HYDROXYTRYPTAMINE RELEASE IN RAT DORSAL RAPHE NUCLEUS IS CONTROLLED BY 5-HT1A, 5-HT1B AND 5-HT1D AUTORECEPTORS
    DAVIDSON, C
    STAMFORD, JA
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (06) : 1107 - 1109
  • [42] Modulation of the hypoxic sensory response of the carotid body by 5-hydroxytryptamine:: role of the 5-HT2 receptor
    Jacono, FJ
    Peng, YJ
    Kumar, GK
    Prabhakar, NR
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2005, 145 (2-3) : 135 - 142
  • [43] PHARMACOLOGICAL CHARACTERIZATION OF RP-62203, A NOVEL 5-HYDROXYTRYPTAMINE 5-HT2 RECEPTOR ANTAGONIST
    DOBLE, A
    GIRDLESTONE, D
    PIOT, O
    ALLAM, D
    BETSCHART, J
    BOIREAU, A
    DUPUY, A
    GUEREMY, C
    MENAGER, J
    ZUNDEL, JL
    BLANCHARD, JC
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (01) : 27 - 36
  • [44] Excitatory effects of 5-hydroxytryptamine on the medial vestibular nuclear neuron via the 5-HT2 receptor
    Jeong, HS
    Lim, YC
    Kim, TS
    Heo, T
    Jung, SM
    Cho, YB
    Jun, JY
    Park, JS
    NEUROREPORT, 2003, 14 (15) : 2001 - 2004
  • [45] BLOOD AND URINE 5-HYDROXYTRYPTOPHAN AND 5-HYDROXYTRYPTAMINE LEVELS AFTER ADMINISTRATION OF 2 5-HYDROXYTRYPTAMINE PRECURSORS IN NORMAL MAN
    WA, TCLK
    BURNS, NJT
    WILLIAMS, BC
    FREESTONE, S
    LEE, MR
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (03) : 327 - 329
  • [46] Molecular modelling of the 5-hydroxytryptamine receptors
    Wishart, G
    Bremner, DH
    Sturrock, KR
    RECEPTORS & CHANNELS, 1999, 6 (04) : 317 - 335
  • [47] 5-HYDROXYTRYPTAMINE - NEUROTRANSMITTER OF BOVINE RETINA
    THOMAS, TN
    REDBURN, DA
    EXPERIMENTAL EYE RESEARCH, 1979, 28 (01) : 55 - 61
  • [48] HANDLING OF 5-HYDROXYTRYPTAMINE BY PLATELETS IN MIGRAINE
    MACGREGOR, EA
    BIRD, N
    RIDLER, C
    WILKINSON, MIP
    HEADACHE, 1992, 32 (02): : 68 - 72
  • [49] HANDLING OF 5-HYDROXYTRYPTAMINE BY PLATELETS IN MIGRAINE
    MACGREGOR, EA
    BIRD, N
    RANSON, R
    RIDLER, C
    WILKINSON, MIP
    HEADACHE, 1992, 32 (06): : 305 - 309
  • [50] 5-hydroxytryptamine and interval timing behaviour
    Ho, MY
    Velázquez-Martínez, DN
    Bradshaw, CM
    Szabadi, E
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 71 (04) : 773 - 785
12345